Stock Market News
Latest financial news · Updated Jul 16, 2026
SpaceX by the numbers: Six charts map businesses behind the largest-ever IPO
The panelists agree that SpaceX's $1.77T valuation is a high-risk, high-reward bet on future cash flows from Starlink, xAI, and …
Is VICI Properties Stock Underperforming the Nasdaq?
Despite VICI's strong fundamentals, such as high gross margins and long-term leases, the panel is concerned about its high exposure …
A 'small' $5M: Bobbi Althoff asked Mark Cuban to buy her a house. His answer shows why homeownership is out of reach
The panel consensus is bearish on the article's promotion of private real estate platforms as a solution to California's high …
Australian insurer Steadfast gets $5.4bn offer from Amwins and Dragoneer
The panel is bearish on the Amwins-Dragoneer bid for Steadfast, citing regulatory approval uncertainties, tight due diligence windows, and potential …
Dyne Therapeutics (DYN) Concludes Phase 1/2 ACHIEVE Trial Enrollment
The panel agrees that the enrollment milestone for Dyne's ACHIEVE trial is significant but emphasizes the critical importance of the …
Crinetics Pharmaceuticals (CRNX) is One of the Best AI Driven Biotech Stocks, Here is Why
The panel consensus is bearish on Crinetics (CRNX), with the key takeaway being that the company's 'AI-driven' biotech narrative is …
Catalyst and Momentum Trials Data Fuels Optimism for Corcept Therapeutics (CORT)
The panel consensus is bearish on Corcept's (CORT) expansion into the diabetes/hypertension market, citing lack of hard trial metrics, safety …
Mineralys Therapeutics (MLYS) to Repurchase Potential Royalties for Lorundrostat
The panel is largely bearish on Mineralys' (MLYS) decision to raise funds via equity and debt to buy out Tanabe …
What Makes Denali Therapeutics (DNLI) One of the Best AI Driven Biotech Names
The panel is bearish on Denali Therapeutics due to the failed BIIB122 trial, narrow genetic subset for potential success in …
Treasury clashes with No 10 over war bonds
The panel consensus is bearish, with all participants agreeing that the Treasury's rejection of 'war bonds' is a negative development. …
Rates tick up after hot inflation and strong jobs numbers: Mortgage and refinance interest rates today
Panel consensus is bearish, expecting housing affordability to worsen, transaction volumes to stagnate, and home prices to remain supported by …
Humana divests interest in end-of-life provider Gentiva valued at $900M
Humana's sale of its 40% Gentiva stake signals a strategic pivot towards its CenterWell primary care model, but raises concerns …